Medical Treatment & Prevention

Description

No matching items found.

People

  

  

  

1 of 8

  

  

  

• ALUCK THIPAYARAT
• BOONSERM KAEWKAMNERDPONG
• CHANYAPORN BSTIELER
• DUANGHATHAI WIWATRATANA
• DUJDUAN WARAHO

Publications

  

  

  

7 of 17

  

  

  

• ● Development of a Compartment Model to Study the Pharmacokinetics of Medical THC after Oral Administration; Thanachok Mahahong, Teerapol Saleewong; 2024; Journal article
• ● Development of a genetically integrated PBPK model for predicting uric acid homeostasis in humans; Kaewlin N., Liangruksa M., Laomettachit T.; 2021; Journal article
• ● Development of an Antibody Targeting Variants of the SARS-CoV-2 Spike Protein; Puridech Bubphamanee,, Praopim Limsakul, et al.; 2025; Journal article
• ● Development of Passive Arthroscope Holder with Counter Balance Mechanism for Gravity Compensation; S Vongbunyong, P Romtrairat, T Turajane
  ; 2022; Poster
• ● Differential dysregulation of glutamate transporter expression contributes to relative susceptibility to methylmercury of wild-type, and Nrf2-knockout derived spinal astrocytes.; Duanghathai Wiwatratana, William D. Atchison; 2021; Poster

Projects

  

  

  

1 of 3

  

  

  

• ● Characterizing tissue biomechanical properties for development of artificial tissue; TEERANOOT CHANTHASOPEEPHAN - Department of Mechanical Engineering
• ● Cosmeceutical mask sheet for skin care whitening and antiaging agent using innovative cellulose acetate electrospun fibers doped with a natural oxyresveratal ; NAKORN NIAMNONT - Department of Chemistry
• ● Development of a phototriggerable liposomal delivery system for emblica fruit extract for the treatment of psoriasis; KWANCHANOK PASUWAT - Department of Chemical Engineering
• ● Development of nanobodies specific to the CHRD domain of proprotein convertase subtilisin/kexin type 9 (PCSK9) as biologics for treatment of high blood LDL-cholesterol level; DUJDUAN WARAHO - Faculty of Engineering
• ● Development of nanobody specific to receptor binding domain of SARS-CoV-2 for applying as antibody drug for COVID-19 treatment; DUJDUAN WARAHO - Faculty of Engineering